MOBILE, Ala. (WKRG) — Cancer researchers with the USA Health Mitchell Cancer Institute and the University of South Alabama have identified a potential biomarker for early diagnosis and prognosis of pancreatic cancer. Cancer researchers identified the TOMM22 protein and could also be a useful therapeutic target. “Pancreatic cancer is a very aggressive disease that spreads […]
Cancer researchers with the USA Health Mitchell Cancer Institute and the University of South Alabama have identified a potential biomarker for early diagnosis and prognosis of pancreatic cancer.
Early detection and effective treatment of triple-negative breast cancer (TNBC) are the ultimate goals of a study by researchers at the USA Health Mitchell Cancer Institute and the University of …